Ligand Receives $4 Million from Expansion of Two OmniAb® License Agreements
Go back to Ligand Receives $4 Million from Expansion of Two OmniAb® License Agreements| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 287.63 +3.36 (1.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $284.27 | 52 Week High | $139.79 | |||
| Open | $285.73 | 52 Week Low | $82.07 | |||
| Day High | $290.33 | P/E | 668.91 | |||
| Day Low | $281.69 | EPS | $0.43 | |||
| Volume | 102,229 | |||||
